We talk to Sunil Krishnan, the new co-Editor-in-Chief of Cancer Nanotechnology.
Matthew holds an MChem in Chemistry from the University of Sheffield and an MSc in Forensic Medical Sciences from Queen Mary, University of London. Working in scientific publishing since 2010, Matthew joined Springer Nature in July 2015 as a Journal Development Editor. Originally hailing from near Manchester, UK, Matthew is now based in Heidelberg, Germany.
Latest posts by Matthew Smyllie (see all)
- An interview with Sunil Krishnan, new co-EiC of Cancer Nanotechnology - 6th November 2018
- A new EiC and new identity for Cancer Nanotechnology - 5th November 2018
We introduce Sunil Krishnan as the new co-Editor-in-Chief of Cancer Nanotechnology and welcome the journal to the BMC family.